Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy].

Molekuliarnaia biologiia·2026

Same author

Influence of the Breast Tumor Stromal Fibroblasts on Immunological Processes In Vitro.

Bulletin of experimental biology and medicine·2025

Same author

Plasma pharmacokinetics and tissue distribution of L-lysine α-oxidase from Trichoderma cf. aureoviride RIFAI VKM F- 4268D in mice.

Amino acids·2021

Same author

[Regulated expression systems for gene therapy].

Molekuliarnaia biologiia·2013

Same author

[Cytotoxicity of lysomustine and its isomers, and their potential use for selection of cells].

Bioorganicheskaia khimiia·2012

Same author

[Involvement of guanine nucleotide exchange factor xLARG in epiboly of cells of the animal pole of Xenopus laevis embryos].

Biofizika·2011

Search research articles

Related Experiment Video

Updated: May 11, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

[Mesenchymal stem cells as an antitumor therapy tool].

S Sh Karshieva, L S Krasikov, A V Beliavskiĭ

Molekuliarnaia Biologiia

|May 28, 2013

Summary

Mesenchymal stem cells show promise for cancer gene therapy by delivering therapeutic genes directly to tumors. This targeted approach has demonstrated significant antitumor effects in preclinical models, though clinical application requires further development.

Area of Science:

Oncology
Regenerative Medicine
Molecular Biology

Background:

Developing low-toxicity, high-selectivity antitumor agents is crucial for cancer gene therapy.
Mesenchymal stem cells (MSCs) exhibit natural tumor-homing properties, making them ideal vectors for targeted gene delivery.
Current therapeutic genes for MSC delivery include enzymes, cytokines, and apoptosis-inducing factors.

Purpose of the Study:

To evaluate the potential of mesenchymal stem cells as vehicles for targeted cancer gene therapy.
To assess the efficacy of MSC-mediated delivery of therapeutic genes in preclinical tumor models.

Main Methods:

Utilizing mesenchymal stem cells for targeted delivery of genes encoding therapeutic proteins (e.g., enzymes, cytokines, TRAIL).
Employing experimental models of various tumor etiologies, including brain and lung metastases in animals.

More Related Videos

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

Published on: January 7, 2019

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Related Experiment Videos

Last Updated: May 11, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

Published on: January 7, 2019

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Main Results:

Mesenchymal stem cells successfully delivered therapeutic genes to tumor sites in experimental models.
Significant antitumor effects were observed in animals treated with MSC-delivered therapeutic genes.
MSC-mediated gene therapy demonstrated efficacy against tumors with different origins and metastatic spread.

Conclusions:

Mesenchymal stem cells are effective vehicles for targeted delivery of therapeutic genes in preclinical cancer models.
MSC-based gene therapy holds significant potential for treating various cancers, including metastatic disease.
Further technical advancements are necessary to translate this promising therapeutic strategy into clinical practice.